Topic: Oncology

Researchers from Chulalongkorn University, a public university in Thailand, have created an AI-based system for […]

Perth-based medical device firm OncoRes Medical has bagged $12.5 million in funding to support its […]

The diagnostic imaging provider RadNet has secured two software clearances from the FDA to help […]

DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for […]

Researchers at Columbia University School of Engineering and Applied Science developed an advanced organ-on-a-chip system […]

Digital cancer care company Kaiku Health has entered into a strategic partnership with pharma and diagnostics giant Roche to […]

Researchers at the University of Waterloo in Canada created a soft robotic sleeve to treat […]

Brisbane-based cancer care provider Icon Group has teamed up with Siemens Healthineers’ Varian, a cancer […]

With 1 in 8 women in the U.S. developing breast cancer in her lifetime and […]

Fujitsu has teamed up with Southern Tohoku General Hospital in Fukushima, Japan for a joint […]

AI tool receives UK regulatory approval to support urgent skin cancer cases Artificial intelligence (AI) […]

For those diagnosed with colorectal cancer, surgery has been the only option that offers a […]

The first cell therapies for cancer employ T cells turned into targeted tumor fighters. Nkarta […]

Chalk up another setback to oral selective estrogen receptor degraders (SERDs). In the wake of […]

A patient-specific 3D-printed technology designed to improve the accuracy of breast cancer surgery (specifically, lumpectomies) […]

Ankyra Therapeutics is bringing on outside expertise to support its bid to unlock the power of cytokines. […]

Koya Medical this week announced positive results from a small, ongoing trial comparing its Dayspring […]

Boston Scientific (NYSE:BSX) today touted data from a Phase 3 clinical trial of its TheraSphere […]

Biotechs targeting the “don’t eat me” signal cancer cells use to avoid the immune system […]

ConcertAI, a healthcare data science and AI company that focuses on oncology, is expanding its […]

Just two months after getting a swift approval for its closely watched KRAS lung cancer […]

Seven years ago, AbbVie penned an early-stage deal with Google/Alphabet’s life sciences division Calico: The […]

Patients with head and neck cancer frequently require surgical removal of lymph nodes from the […]

Researchers at RMIT University in Melbourne, Australia, created an AI system that can identify prostate […]

Researchers at Kumamoto University in Japan have designed an inexpensive and convenient filter that can […]

Cardinal Health (NYSE:CAH) announced today that the FDA approved its Lymphoseek injection for pediatric use. […]

Researchers at Linköping University, Sweden, and the Medical University of Graz, Austria have developed an […]

Vysioneer, a provider of artificial intelligence (AI) for cancer care, has received clearance from the […]

Researchers at MIT and the Indian Institute of Technology Madras have developed a 3D-printed microfluidic […]

Bluestar Genomics announced today that it received FDA breakthrough device designation for its pancreatic cancer […]

Quibim, a global medical imaging analysis specialist, has joined Highlight Therapeutics, a clinical-stage company specialising in […]

Momentum in biotech IPOs continued this week as four more companies made their stock market […]

Takeda Pharmaceutical (NYSE:TAK) announced that it is acquiring Maverick Therapeutics in a deal worth up […]

Vividion Therapeutics has technology that finds ways to hit promising disease targets that were previously […]

ForDoz Pharma announced today that it entered into an agreement with LipoMedix to manufacture its […]

Study results presented at the 2021 annual meeting of the Orthopaedic Research Society (12–16 February, […]

NovoCure (NSDQ:NVCR) announced that it closed its previously announced offering of $575 million in 0% convertible […]

Philips has just unveiled its Azurion Lung Edition system that combines a number of technologies […]

The rumors are indeed true – Illumina is attempting to acquire early cancer detection specialist […]